Funds holding Taysha Gene Therapies Inc
ISIN US8776191061 · United States
- Fund holders
- 154
- Of which ETFs
- 43 111 other funds
- Value held
- 242.9M $
- Share of capital
- 15.6 % of 325.8M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 16,393 | 73.3K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 15,406 | 68.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 15,289 | 69.3K $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 15,007 | 67.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 14,523 | 92.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 14,135 | 63.2K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 13,977 | 89.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 13,671 | 61.9K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 13,626 | 61.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 12,648 | 57.3K $ | 0.06 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 12,369 | 79K $ | 1.53 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 12,068 | 53.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 11,693 | 52.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 10,969 | 49.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 10,826 | 69.2K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 10,179 | 65K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 9,600 | 42.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 9,569 | 43.3K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AQR Small Cap Multi-Style Fund AQR Funds | 9,303 | 41.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 8,966 | 40.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 7,946 | 50.8K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 7,627 | 34.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 7,298 | 46.6K $ | 0.18 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 6,613 | 30K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 6,486 | 29K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 5,870 | 37.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 5,370 | 24K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 5,210 | 23.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 5,157 | 23.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 4,841 | 30.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 4,760 | 30.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 4,750 | 21.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,361 | 19.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TEXAS CAPITAL TEXAS EQUITY INDEX ETF Texas Capital Funds Trust | 3,264 | 14.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 3,049 | 19.5K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 3,045 | 19.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 2,653 | 17K $ | 0.46 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 2,493 | 15.9K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,415 | 6.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 1,073 | 4.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,021 | 4.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 1,011 | 6.5K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,000 | 4.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 739 | 3.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 736 | 3.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Texas Equity ETF iShares Trust | 707 | 3.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 558 | 2.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 504 | 2.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 403 | 2.6K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 296 | 1.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 227 | 1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 221 | 987.9 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 68 | 308 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 57 | 254.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Neuroscience and Healthcare ETF iShares Trust | 1.53 % | as of Apr 30, 2026 ↗ |
| Polen 5Perspectives Small Growth Fund FundVantage Trust | 1.02 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.82 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.80 % | as of Feb 28, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 0.46 % | as of Apr 30, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.40 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.35 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.34 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.34 % | as of Feb 28, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.33 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 154 | +10 | 50,970,398 | +7.1 % |
| 2026Q1 | 144 | +19 | 47,575,792 | +13.7 % |
| 2025Q4 | 125 | +17 | 41,848,472 | +13.0 % |
| 2025Q3 | 108 | -1 | 37,036,272 | +7.7 % |
| 2025Q2 | 109 | -4 | 34,383,645 | -14.7 % |
| 2025Q1 | 113 | +3 | 40,289,861 | +5.6 % |
| 2024Q4 | 110 | +53 | 38,154,264 | +37.5 % |
| 2024Q3 | 57 | +30 | 27,748,609 | +11.6 % |
| 2024Q2 | 27 | +3 | 24,857,419 | +0.5 % |
| 2024Q1 | 24 | +5 | 24,725,557 | +248.6 % |
| 2023Q4 | 19 | 7,093,392 |
Institutional managers
183 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 23,555,648 | 105.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 22,369,645 | 100M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 21,700,000 | 97M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 18,365,608 | 82.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 18,000,000 | 80.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 17,965,371 | 80.3M $ | as of Mar 31, 2026 |
| FMR LLC | 14,321,255 | 64M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 13,680,248 | 61.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,209,078 | 50.1M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 8,859,911 | 39.6M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 8,829,913 | 39.5M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 5,654,340 | 25.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 5,531,955 | 24.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 4,427,301 | 19.8M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 4,004,756 | 17.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,281,820 | 14.7M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 3,250,000 | 14.5M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 2,979,429 | 13.3M $ | as of Mar 31, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2,883,301 | 12.9M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 2,812,010 | 11.4M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,722,165 | 12.2M $ | as of Mar 31, 2026 |
| SG Americas Securities, LLC | 2,176,742 | 9.7K $ | as of Mar 31, 2026 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,944,671 | 8.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,814,318 | 8.1M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,808,599 | 8.1M $ | as of Mar 31, 2026 |
Declared shareholders of Taysha Gene Therapies Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 7.00 % | 20,689,084 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vestal Point Capital, LP and 1 other | 6.30 % | 18,000,000 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Taysha Gene Therapies Inc". https://titelia.com/en/stocks/taysha-gene-therapies-inc-US8776191061